BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38053290)

  • 1. Harnessing CRISPR-Cas adaptation for RNA recording and beyond.
    Oh GS; An S; Kim S
    BMB Rep; 2024 Jan; 57(1):40-49. PubMed ID: 38053290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
    Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration.
    Xiao Y; Ng S; Nam KH; Ke A
    Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cas1 and Cas2 From the Type II-C CRISPR-Cas System of
    He Y; Wang M; Liu M; Huang L; Liu C; Zhang X; Yi H; Cheng A; Zhu D; Yang Q; Wu Y; Zhao X; Chen S; Jia R; Zhang S; Liu Y; Yu Y; Zhang L
    Front Cell Infect Microbiol; 2018; 8():195. PubMed ID: 29951376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creating memories: molecular mechanisms of CRISPR adaptation.
    Lee H; Sashital DG
    Trends Biochem Sci; 2022 Jun; 47(6):464-476. PubMed ID: 35236570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cas1-Cas2 complex formation mediates spacer acquisition during CRISPR-Cas adaptive immunity.
    Nuñez JK; Kranzusch PJ; Noeske J; Wright AV; Davies CW; Doudna JA
    Nat Struct Mol Biol; 2014 Jun; 21(6):528-34. PubMed ID: 24793649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas adaptation in Escherichia coli.
    Mitić D; Bolt EL; Ivančić-Baće I
    Biosci Rep; 2023 Mar; 43(3):. PubMed ID: 36809461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spacer acquisition from RNA mediated by a natural reverse transcriptase-Cas1 fusion protein associated with a type III-D CRISPR-Cas system in Vibrio vulnificus.
    González-Delgado A; Mestre MR; Martínez-Abarca F; Toro N
    Nucleic Acids Res; 2019 Nov; 47(19):10202-10211. PubMed ID: 31504832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural plasticity and in vivo activity of Cas1 from the type I-F CRISPR-Cas system.
    Wilkinson ME; Nakatani Y; Staals RH; Kieper SN; Opel-Reading HK; McKenzie RE; Fineran PC; Krause KL
    Biochem J; 2016 Apr; 473(8):1063-72. PubMed ID: 26929403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer.
    Richter C; Dy RL; McKenzie RE; Watson BN; Taylor C; Chang JT; McNeil MB; Staals RH; Fineran PC
    Nucleic Acids Res; 2014 Jul; 42(13):8516-26. PubMed ID: 24990370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spacer capture and integration by a type I-F Cas1-Cas2-3 CRISPR adaptation complex.
    Fagerlund RD; Wilkinson ME; Klykov O; Barendregt A; Pearce FG; Kieper SN; Maxwell HWR; Capolupo A; Heck AJR; Krause KL; Bostina M; Scheltema RA; Staals RHJ; Fineran PC
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5122-E5128. PubMed ID: 28611213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase-Cas1 fusion protein.
    Silas S; Mohr G; Sidote DJ; Markham LM; Sanchez-Amat A; Bhaya D; Lambowitz AM; Fire AZ
    Science; 2016 Feb; 351(6276):aad4234. PubMed ID: 26917774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.
    Vorontsova D; Datsenko KA; Medvedeva S; Bondy-Denomy J; Savitskaya EE; Pougach K; Logacheva M; Wiedenheft B; Davidson AR; Severinov K; Semenova E
    Nucleic Acids Res; 2015 Dec; 43(22):10848-60. PubMed ID: 26586803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DnaQ exonuclease-like domain of Cas2 promotes spacer integration in a type I-E CRISPR-Cas system.
    Drabavicius G; Sinkunas T; Silanskas A; Gasiunas G; Venclovas Č; Siksnys V
    EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29891635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation.
    Musharova O; Klimuk E; Datsenko KA; Metlitskaya A; Logacheva M; Semenova E; Severinov K; Savitskaya E
    Nucleic Acids Res; 2017 Apr; 45(6):3297-3307. PubMed ID: 28204574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-spacer integration reporter plasmids reveal distinct genuine acquisition specificities among CRISPR-Cas I-E variants of Escherichia coli.
    Díez-Villaseñor C; Guzmán NM; Almendros C; García-Martínez J; Mojica FJ
    RNA Biol; 2013 May; 10(5):792-802. PubMed ID: 23445770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.
    Heussler GE; Miller JL; Price CE; Collins AJ; O'Toole GA
    J Bacteriol; 2016 Nov; 198(22):3080-3090. PubMed ID: 27573013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Reverse Transcriptase-Cas1 Fusion Protein Contains a Cas6 Domain Required for Both CRISPR RNA Biogenesis and RNA Spacer Acquisition.
    Mohr G; Silas S; Stamos JL; Makarova KS; Markham LM; Yao J; Lucas-Elío P; Sanchez-Amat A; Fire AZ; Koonin EV; Lambowitz AM
    Mol Cell; 2018 Nov; 72(4):700-714.e8. PubMed ID: 30344094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate generation for endonucleases of CRISPR/cas systems.
    Zoephel J; Dwarakanath S; Richter H; Plagens A; Randau L
    J Vis Exp; 2012 Sep; (67):. PubMed ID: 22986408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure reveals why genome folding is necessary for site-specific integration of foreign DNA into CRISPR arrays.
    Santiago-Frangos A; Henriques WS; Wiegand T; Gauvin CC; Buyukyoruk M; Graham AB; Wilkinson RA; Triem L; Neselu K; Eng ET; Lander GC; Wiedenheft B
    Nat Struct Mol Biol; 2023 Nov; 30(11):1675-1685. PubMed ID: 37710013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.